chrisvoncsefalvay/vaers-outcomes huggingface dataset:
didn't actually have a fever but went between cold and warm; her arm was hurting; she wasn't feeling great; neuropathic side effects; electrical tingling shock that goes up in her feet and sometimes into her leg; her nerves spazzing out; it's really painful; electrical tingling shock that goes up in her feet and sometimes into her leg; a headache which was described as "not a severe one, a minor one"; more tired than usual; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (didn't actually have a fever but went between cold and warm), PAIN IN EXTREMITY (her arm was hurting), MALAISE (she wasn't feeling great), NEURALGIA (neuropathic side effects) and ELECTRIC SHOCK SENSATION (electrical tingling shock that goes up in her feet and sometimes into her leg) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression, Bipolar disorder and Social anxiety disorder.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (didn't actually have a fever but went between cold and warm), PAIN IN EXTREMITY (her arm was hurting), MALAISE (she wasn't feeling great), NEURALGIA (neuropathic side effects), ELECTRIC SHOCK SENSATION (electrical tingling shock that goes up in her feet and sometimes into her leg), MUSCLE SPASMS (her nerves spazzing out), PAIN (it's really painful), PARAESTHESIA (electrical tingling shock that goes up in her feet and sometimes into her leg), HEADACHE (a headache which was described as "not a severe one, a minor one") and FATIGUE (more tired than usual). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form. At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (didn't actually have a fever but went between cold and warm), PAIN IN EXTREMITY (her arm was hurting), MALAISE (she wasn't feeling great), HEADACHE (a headache which was described as "not a severe one, a minor one") and FATIGUE (more tired than usual) had resolved and NEURALGIA (neuropathic side effects), ELECTRIC SHOCK SENSATION (electrical tingling shock that goes up in her feet and sometimes into her leg), MUSCLE SPASMS (her nerves spazzing out), PAIN (it's really painful) and PARAESTHESIA (electrical tingling shock that goes up in her feet and sometimes into her leg) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported by reporter It was reported that the caller did not know the name of medications of the top of her head. Patient's physician stated that she would be fine to receive the second dose and patient had a physical examination scheduled in a few weeks
WITH BURNING AT SITE OF INJECTION. WITH NAUSEA AND LIGHT HEADEDNESS, STOMACH ACHE.
Vial was not diluted prior to giving dose. Had only worked with adult doses before and failed to realized children vial did not come pre-diluted like the adult. Child received 0.2ml of undiluted dose (20mcg) rather than 10mcg (diluted.)
Reaction started with sudden onset of pain within 3 hours after injection was given. Injection site is high on right arm towards the back of arm. Almost shoulder level. I took 3 Ibuprofen before bedtime on the 18th. (600mg). I woke up on the morning of the 19th not feeling well. Symptoms included fatigue, mild headache, chills and increased mid morning. I took another 600 of Ibuprofen and rested for the remainder of the day. At bedtime I took 600 mg Ibuprofen. Today is the 20th.  I do feel better today. My arm is still painful but better.
Fever, chills, body aches and pains, vomiting, headaches, rapid heart rate, inability to sleep, nausea 7 days and counting, diarrhea, lack of energy
A felt sick Thursday night going into Friday morning, I've had diarrhea throughout the day and feeling tired even though I've been staying at home.
18 yo male with no significant PMH presented to the hospital on 6/2/2021 with c/o chest pain and SOB.  Per patient and his mother at bedside, he received the second dose of Pfizer vaccine on Sunday. Day after had mild headache, aches, arm pain and abdominal pain.  Last night woke up with chest pain and SOB.  They called his pediatrician who recommended they come to the ER for evaluation.  In ED was found to have elevated troponin and EKG changes.  CTA negative for PE.   EKG  showed ST elevations/ PR depressions inferior/ lateral leads concerning for pericarditis.  Patient was seen by cardiology and diagnosis of myo/pericarditis  was made.  Patient was prescribed Aspirin 325 mg TID and Protonix 40 mg QD for GI prophylaxis.  Patient will follow up with the cardiologist 1 week after discharge for further management and medication adjustments.
Patient received Pfizer as their 2nd dose instead as Moderna, which was their 1st dose.
On November 22, 2022, Patient received the Moderna Bivalent booster at the Mass Vaccination event. The patient received vaccine at 10:15, Moderna Bivalent lot # 016H22A, in her left Deltoid. At 10:28 she started to fill dizzy/lightheaded, nursing staff had her sit down and started to triage. She presented A&Ox3, bilaterally lung sounds clear, BP 145/93, pulse 72, diaphoretic, no s/s of respiratory distress, O2 was given by nasal cannula at 2 liters. Reassessed at 10:30 BP 139/79, pulse 70, A&Ox3, bilaterally lung sounds clear, diaphoretic, patient laid down on liter. At 10:38 BP 128/70, pulse 68, dry, A&Ox3. At 10:42, O2 discontinued, and patient moved from lying down to sitting in chair BP 125/74, pulse 68, patient stated she was feeling less dizzy and wanted to stand up. At 10:43 patient stood up with assistance, reassessed by nurse, patient stated she was ready to go to her car. Nurse and medic walked patient to the car, where spouse was waiting for her. Nurse provided local emergency room contact information and recommended patient follow up with PCP. Patient and spouse verbalized understanding.
he said he was going where he didn't want to go and darkness in front of his eyes; I saw him swaying back and forth in the shower and about to fall; he was conscious but his lips were pale; This is a spontaneous report received from a contactable consumer. The reporter is the parent.  A 5-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 22Nov2021 (Lot number: FK5127) at the age of 5 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The vaccine was administered in pharmacy or drug store. There were no other vaccine in four weeks and no other medications in two weeks. The patient did not have Covid-19 prior vaccination, was not tested for Covid-19 post vaccination. He had no known allergies and no other medical history. The following information was reported: SYNCOPE (medically significant) with onset 23Nov2021 08:30, outcome "recovered", described as "he said he was going where he didn't want to go and darkness in front of his eyes"; PRESYNCOPE (non-serious) with onset 23Nov2021 08:30, outcome "recovered", described as "I saw him swaying back and forth in the shower and about to fall"; PALLOR (non-serious) with onset 23Nov2021 08:30, outcome "recovered", described as "he was conscious but his lips were pale". The parent reported that patient took vaccine yesterday evening. He was okay. In the morning, he woke up around 8:30 am and went to shower. After 15-20 minutes in shower, the parent saw him swaying back and forth in the shower and about to fall. The parent picked patient up, he was conscious but his lips were pale. The parent asked him what happened and he said "he was going where he didn't want to go" and darkness in front of his eyes. Therapeutic measures were not taken as a result of syncope, presyncope, pallor.   Follow-up attempts are completed. No further information is expected.
Fully vaccinated, not boosted.   Asymptomatic COVID breakthrough with inpatient hospital stay.
Extreme tenderness to site (L deltoid) and warmth, body aches, chills, swelling.
1 1/2 hours after injection client called to report severe pain in left arm with edema and erythema, also stated had TD and Hepatitis in same arm on 1/17/2006. No problem breathing instructed to Tylenol or Advil for pain, 25mg Benadryl and apply ice see PCP if not improvement.
Report 2010116501 described injection site warmth in a 41 year old female who received hep B vaccine(Engerix-B). Allergies, medical history, and concomitant medications were not specified. On 05/03/2001, the vaccinee received a 1cc subcutaneous dose of Engerix-B. It was not specified whether or not she had received previous doses of Engerix-B. On 05/04/2001, she began having redness, warmth, and itching at the injection site on her left arm. As of 05/07/2001, the redness is a red circular area around the injection site.
PATIENT REPORTED TODAY AS HIS FIRST DOSE. PFIZER GIVEN. LATER STATED HE RECEIVED MODERNA BACK IN FEBRUARY.
Red irritation & swelling @ inject site; red, swollen urticaria w/itching from lt deltoid to wrist;
Vaccine received on 1-7-21.   On 1-15-21 woke with blood blister at injection site, shadow bruising over most of upper arm, and large (greater than golf ball) inflamation at anterior shoulder/arm (believe may have been a lymph node.    Shadow bruising disappeared within few hours.  Blood blister disappeared within a day.  Enlarged golf ball size area anterior shoulder/arm swelling reduced, but still present.  no signs of any of these things prior to appearance on 1-15-21.  No injury sustained to cause.
@ around 3pm on 16JUL91 recvd DTP/OPV/HIB & t98.1; 17JUL91 mom reports t101-103 w/forehead strips; 18JUL91 t101.8, pt fussy, no heart murmur noted @ MD office; 19JUL91 t104, diarrhea;
Presents for weakness & nausea x10 days. Admit for COVID, near syncope, AKI on CKD. Tx: O2, solumedrol, abx, tessalon, zinc; not a candidate for remdesivir due to renal failure. DC to home
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Severe, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Severe, Additional Details: Blistering in mouth, urgern diagnosed with infection in arm. Severe redness/sweliing at injection site, more than six inches surrounding site. TPrescribed cephalexin 500 mg (as needed if arm swelling continues, pt did not take) and valtrex 1 gram for fever blisters
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.   Reporter did not allow further contact
always got sick; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient's family member) via social media on 05-Dec-2020.  This case involves a female patient of unknown age who always got sick (illness), while she received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown.  On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, unspecified time after receiving the vaccine, the reporter stated that the patient worked in a hospital and had to get one every year. She always got sick (illness).   It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.      The reporter assessed the causal relationship with suspect vaccine as related.
presented to ED dept confused, incr n/v, weakness. Received palliative carex4 days. deceased 05/24
Intense headache next day to the vaccine. Arm sore. Plus my Period comes 17 days early.
Fever - chills, cough - ache all over, dizzy light headed tired heart beating fast and irregular. Lasted 2 1/2 days took TYLENOL cough med antibiotic.
Sore Neck - Night of the injection Sore Arm - Left arm starting day of injection and lasting 3 days Swollen Lymph Nodes - Left arm pit starting 3 days after the injection and continuing to day 4  No treatment applied for any adverse event
high heart rate of 130s, headache, extreme weakness, high blood pressure,  nausea and vomiting, fever and headache, chills, pain all over
Patient's arm red and swollen at injection site. Pain worsened to shoulder area. Prescribed Methapred injection and prednisone by mouth.
right sided subclavicular lymphadenopathy with large lymph node noted right side of subclavicular notch.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 13Jan2021 (Lot number: EL3429) at the age of 62 years as dose 2, single and administered in arm right, administration date 21Dec2020 (Lot number: EJ1683) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Recurrent Herpes Meningitis" (unspecified if ongoing). There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 29Dec2021, outcome "not recovered", described as "right sided subclavicular lymphadenopathy with large lymph node noted right side of subclavicular notch.". The event "right sided subclavicular lymphadenopathy with large lymph node noted right side of subclavicular notch." was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of lymphadenopathy.  Additional information: Adverse event resulted into doctor or other healthcare professional office/clinic visit. The patient received treatment of chest x-ray, ct scan, lab work and pain medication. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine and no other medications the patient received within 2 weeks of vaccination. The treatment received for the adverse event as pain medication. The patient was not diagnosed with Covid-19, prior to vaccination and since the vaccination the patient has not tested for Covid-19 No allergies to medications, food and other products.  No follow-up attempts are possible. No further information is expected.
Flu symptoms, laryngitis for 3 weeks starting about Nov 25 (rest, liquids) followed by mild case of covid Dec. 20, 2022  (paxlovid treatment)
Pt arrived at the clinic requesting a PPCV 23. The pt received a PCV13.
Provider Summary "Shortness of breath. 63-year-old  male who had been in his typical state of health up until 2 days ago.  Patient reports developing progressively worsening shortness of breath.  Breathing difficulties were made worse with activities. Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  treated for congestive heart failure, LVEF of 25-30%, Cardiology consult. Being considered for LifeVest Improving  Cardiac catheterization    Done on  7/5. A LifeVest he being given to the patient Acute hypoxic respiratory failure was in PCU status initially.   was on BiPAP therapy and weaned  as tolerated. Give dose of IV diuretic.  Daily weights and strict I's and O's. Lost nearly 10 lb since admission. CHF with reduced EF. Checked  echocardiogram, LVEF of 25-30%, global hypokinesia. Has added Entresto and spironolactone. Cardiology is doing cardiac catheterization  Done on 07/05 to rule out ischemic element of dilated cardiomyopathy .  Showed Circ:  Circ Mid 50%. RCA:  Mid 50-60%. LV:  EF 20-25%. LifeVest is offered to the patient. Hypertension. Continue patient on home blood pressure medication of Norvasc, hydrochlorothiazide and Lopressor.  Monitor blood pressures and adjust medications as needed. Covid infection, appears mostly incidental on respiratory isolation.  Checked  pro inflammatory and hypercoagulable labs.   oxygen saturations and oxygen requirement is improving after diuresis. Chest x-ray findings not consistent with COVID pneumonia At the time of discharge patient is off isolation for COVID."
Patient reported to have noticed pain during injection. Pain continued for days following. Movement, massage, and medication did not alleviate symptoms. Patient visited her physician. The physician provided oral steroids and muscle relaxers. While on medication, pt's symptoms subsided.  Two days following the completion of oral steroid however the pain has returned. Pt reported that the injection seemed to have been placed higher than what she normally has been accustomed to with previous flu shots.
5/22/06 Severe headache treated with analgesics at home. 5/23/06 Weak, uptunded, combative and admitted. Aphasia. Rule out encephalitis vs vaccine reaction. Received MMR on about 5/16/06. ? where. Pt discharged from hospital 5/27/06, fully recovered.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Oct2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 58 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Known allergies; Walnuts" (unspecified if ongoing). There were no concomitant medications. No Other medication in 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results; (02Jul2022) negative; (08Jul2022) positive; (Jul2022) negative, notes: for 5 days. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical courses: The patient received Paxlovid for COVID 19 Treatment, from 27Jun2022 to 02Jul2022. The patient tested negative on a rapid test on 02Jul after starting Paxlovid on 27Jun. She then tested negative for 5 days until testing positive on 08Jul. Symptoms all returned and feeling pretty bad.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient developed gross hematuria one week after vaccine administration.  This continued until presentation to the office at around 3 weeks after vaccination.  Patient had normal blood pressure, normal vital signs, no swelling or edema.  Exam was unremarkable.  Renal ultrasound showed normal kidneys.  Bloodwork revealed normal kidney function, no anemia, and normal C3/4 with an elevated total complement and elevated speckled ANA, and CRP.  Referred to nephrology for further workup.  Appears to be glomerulonephritis at this time.
1st episode on 4/12: Diarrhea, vomiting, nausea, and acute right lower abdominal pain started about 30 minutes after the vaccination.  Abdominal pain lasted more than 6 hours, went to ER, and took CT to  rule out appendicitis/kidney stone. The pain subsided gradually.  2nd episode on  4/17:  Acute right lower abdominal pain started again, lasted for about 6 hours, subsided after taking  heavy dose of Benadryl
Body aches, fever from date of vaccination and then on 5/16, woke up with significant pain on the right side of chest.
Feeling sick; Runny nose; Itchy eyes; feels like she has the flu; This is a spontaneous report from a non-contactable consumer (Patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Lot Number: Not reported; Expiration date: Not reported) via an unspecified route of administration, administered on 25Feb2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 22Mar2021, the patient experienced feeling sick, runny nose, itchy eyes, feels like she has the flu. The patient is calling about the Pfizer covid vaccine. The patient got the first dose of the vaccination at (Facility name) in (name) on 25Feb2021. Today the patient is supposed to get the second shot but she woke up feeling sick, has a runny nose, itchy eyes and feels like she has the flu. This actually started yesterday. The patient wants to know if she should get her second dose of the vaccine at 2:00pm as scheduled. The outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Without xtensive erythematous reaction at site. Chill/fever/malaise lasting several days.
started as burning sensation on right side of my head (forehead, scull, in front and around ear) developed rash, slightly panful on touch
Fever, severe muscle cramps with whole body aches and pains. Nausea and loss of appetite. Headache and brain fog. The muscle cramps are still affecting me
Received VARIVAX 5/22/08 - on 5/25/08 developed systemic itching with no rash and stabbing flank back pains that has persisted until 5/28/08.
This spontaneous report as received from a registered nurse and refers to a 12 year old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On 15-FEB-2016, the patient was vaccinated with a dose of GARDASIL (dose, route, anatomical location, lot and expiration date were not reported) for prophylaxis. Then on 22-AUG-2016, the patient was vaccinated with a dose of GARDASIL 9 (dose, route, anatomical location, lot and expiration date were not reported) for prophylaxis. No adverse effects were reported. Additional information has been requested.